Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphodiesterase 10A (PDE10A) is an enzyme that degrades both cAMP and cGMP, key regulators of numerous physiological processes. It is highly enriched in the striatum and its inhibition offers therapeutic potential across neurological disorders, cardiovascular diseases, inflammatory conditions, and potentially certain cancers by modulating cell signaling pathways.
Selective inhibition of PDE10A, leading to increased levels of cAMP and cGMP in specific tissues such as the striatum.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphodiesterase 10A (PDE10A).